Camp4 Therapeutics (CAMP) Share-based Compensation (2023 - 2026)

Camp4 Therapeutics has disclosed Share-based Compensation across 4 years of filings, most recently posting $1.5 million for Q1 2026.

• Share-based Compensation for Q1 2026 came in at $1.5 million, up 70.96% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.6 million (up 14.2% YoY), and the FY2025 annual result was $4.0 million, down 0.84% from the prior year.
• Share-based Compensation came in at $1.5 million for Q1 2026 at Camp4 Therapeutics, up from $1.2 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $1.6 million in Q3 2024 to a low of $636000.0 in Q4 2023.
• The 4-year median for Share-based Compensation is $861000.0 (2025), against an average of $987181.8.
• Across the five-year window, Share-based Compensation jumped 120.5% in 2024 and plunged 38.19% in 2025, its largest moves.
• Camp4 Therapeutics' Share-based Compensation stood at $636000.0 in 2023, then grew by 25.31% to $797000.0 in 2024, then soared by 44.42% to $1.2 million in 2025, then grew by 27.89% to $1.5 million in 2026.
• The last three Share-based Compensation figures came in at $1.5 million (Q1 2026), $1.2 million (Q4 2025), and $984000.0 (Q3 2025), per Business Quant data.